Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater increase in risk for liver fibrosis than men with the same risk factors. The ...

Alcohol-associated liver disease (ALD) remains a leading cause of cirrhosis and liver-related mortality worldwide, with few effective therapies.

Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...

Naturally occurring chemicals in cannabis have been shown to reduce cholesterol–and the risk of deadly fatty liver disease, ...

As 1 out of every 3 adults worldwide suffers from the condition, Hebrew University scientists use non-psychoactive substances ...

CBD and CBG may help the liver recharge and clean itself—offering a promising new plant-based strategy against fatty liver disease.

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

GSK has signed an eleventh-hour agreement to give Alfasigma rights to its primary biliary cholangitis (PBC) therapy ...

Alfasigma has agreed to buy the global rights to GSK’s experimental liver disease drug in a deal worth up to $690m.

In experiments on pigs, researchers found that some formula fats can strain the newborn liver far earlier than expected.